News

2020

  • Sep 24
    Company CrisBio Technology

    Algenex inaugura su nueva planta de fabricación de vacunas en Tres Cantos con capacidad de producción de hasta 100 millones de dosis vacunales

    View more
  • Sep 13
    CrisBio Company

    Algenex raises €7.4 million in financing round

    View more
  • Sep 08
    CrisBio Company

    Algenex cierra nueva ronda de financiación por 7,4 millones para afrontar sus nuevos proyectos en salud humana

    View more
  • Aug 07
    Company CrisBio

    Algenex obtiene 470.000 euros del CDTI para desarrollar productos para el control y la prevención del COVID-19

    View more
  • Jul 21
    Company CrisBio

    Algenex and Global DX announce positive evaluation of Herdscreen® ASFV antibody test for African Swine Fever

    View more
  • Jul 15
    Company

    Junta general de accionistas

    View more
  • Jul 08
    Company Science

    Día Mundial de la Zoonosis: Más del 60% de las enfermedades infecciosas humanas provienen de animales

    View more
  • Jul 08
    Company

    Algenex impulsa la creación de una plataforma tecnológica de producción industrial de vacunas en España

    View more
  • May 13
    Science Technology

    Algenex obtiene financiación del CDTI para desarrollar productos contra la COVID-19

    View more
  • May 05
    Company CrisBio

    Algenex advances insect-based vaccine production technology in human health

    View more
  • May 05
    Company CrisBio

    Algenex ha desarrollado una tecnología basada en insectos que aceleraría la producción de nuevas vacunas

    View more
  • Mar 02
    Company CrisBio

    Algenex to open new manufacturing facility and hunt for series C this year

    View more
  • Feb 10
    Science Technology

    Algenex presents at LSX London

    View more

2019

  • Dec 06
    Science Technology

    Bioinnovo, Algenex reinforce vaccine molecule arrangement

    View more
  • Dec 02
    Company Science Technology

    Algenex and FATRO sign commercial license agreement for development of a second CrisBio®-based vaccine

    View more
  • Dec 02
    Company CrisBio Science Technology

    Algenex adds to Fatro relationship with second vaccine license

    View more
  • Oct 26
    Science Technology

    First dossier with CrisBio filed to EMA

    View more
  • Oct 15
    Company Science Technology

    First Algenex CrisBio®-based vaccine submitted to European Medicines Agency

    View more
  • Oct 11
    Company

    Convocatoria de Junta General Extraordinaria de socios

    View more
  • Jul 26
    Company

    Junta General Extraordinaria de socios

    View more
  • May 28
    Company Science Technology

    Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever

    View more
  • May 25
    Science Technology

    ALGENEX supports development of recombinant biologics with €4m funding round

    View more
  • Mar 22
    Science Technology

    ALGENEX selected to present at the Animal Health Investment Innovation Showcase

    View more
  • Mar 13
    Science Technology

    ALGENEX appoints new Strategic Advisory Board (SAB)

    View more
  • Mar 05
    Company Science Technology

    ALGENEX closes funding round and strengthens team with key senior manager appointments

    View more

2018

  • Oct 15
    Company

    Algenex galardonada por la Asociación Española de Científicos

    View more

2017

  • Jun 20
    Company

    ALGENEX galardonada con el Premio del Jurado Ecofin 2017

    View more
  • Mar 29
    Company CrisBio Science Technology

    BIOKIT licenses CRISBIO™ technology to make high quality recombinant proteins for in vitro diagnostics for human use

    View more

2015

  • Sep 08
    Company CrisBio Science Technology

    ALGENEX has signed its first commercial license agreement with FATRO

    View more